Status:
COMPLETED
Mitochondrial DNA Triggering Epidural Related Maternal Fever
Lead Sponsor:
Medical University of Vienna
Conditions:
Mitochondrial DNA
Epidural Related Maternal Fever (ERMF)
Eligibility:
FEMALE
18-45 years
Brief Summary
Background: Giving birth is a critical moment for the mother and the fetus, potentially accompanied by stress, tissue damage, cell injury, placental hypoxia and sometimes multisystem vascular syndrome...
Eligibility Criteria
Inclusion
- women
- between 18 and 45 years
- Para 0 or Para 1
- Gestational week
- Elective procedure 37±0 to 42±0
Exclusion
- younger than 18 years
- Emergency procedures
- No written consent
- Fever \<2 weeks
- Intraoperative conversion from one anesthetic or surgical procedure to another one.
- preeclampsia
- HELLP syndrome
- intrauterine growth reduction
- gestational diabetes mellitus
- autoimmune disease
Key Trial Info
Start Date :
July 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04045223
Start Date
July 1 2019
End Date
June 30 2021
Last Update
January 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Anesthesia, General Intensive Care and Pain Management,Medical University of Vienna
Vienna, Austria, 1090